enGene Therapeutics ENGN
NASDAQ ENGN
$2.41 +0.13 (+5.70%)
At close: Nov 13, 2026 · 4:00 PM EST

enGene Therapeutics (ENGN) Purchase of Investments (2025 - 2026)

Updated

Analysis

enGene Therapeutics (ENGN) Purchase of Investments (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 258.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 919.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 300.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 4.40 Bn
10 enGene Therapeutics 161.50 Mn -832.97 Mn - 42.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 42.38 Mn
Apr 30, 2026 50.21 Mn
Jan 31, 2026 169.19 Mn
Oct 31, 2025 7.75 Mn
Jul 31, 2025 44.67 Mn
Apr 30, 2025 13.76 Mn
Jan 31, 2025 94.67 Mn
API Access

enGene Therapeutics Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=ENGN&period=max&api_key=YOUR_API_KEY